Tower Research Capital (TRC)’s Keros Therapeutics KROS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$29.8K	Buy	2,698 +860	+47%	+$13.3K	﹤0.01%	3177
2025 Q4	$37.4K	Sell	1,838 -285	-13%	-$5K	﹤0.01%	2645
2025 Q3	$33.6K	Sell	2,123 -1,030	-33%	-$15.2K	﹤0.01%	2844
2025 Q2	$42.1K	Buy	3,153 +1,888	+149%	+$25.5K	﹤0.01%	3118
2025 Q1	$12.9K	Sell	1,265 -21,719	-94%	-$252K	﹤0.01%	3416
2024 Q4	$364K	Buy	22,984 +21,145	+1,150%	+$1.1M	0.01%	1274
2024 Q3	$107K	Sell	1,839 -3,084	-63%	-$152K	﹤0.01%	2177
2024 Q2	$225K	Buy	4,923 +4,028	+450%	+$216K	﹤0.01%	1971
2024 Q1	$59.2K	Sell	895 -7,367	-89%	-$437K	﹤0.01%	2161
2023 Q4	$328K	Buy	8,262 +7,625	+1,197%	+$239K	﹤0.01%	1708
2023 Q3	$20.3K	Sell	637 -1,329	-68%	-$49.6K	﹤0.01%	3357
2023 Q2	$79K	Buy	1,966 +826	+72%	+$36.2K	﹤0.01%	2225
2023 Q1	$48K	Buy	1,140 +654	+135%	+$33K	﹤0.01%	2530
2022 Q4	$23K	Sell	486 -2,357	-83%	-$110K	﹤0.01%	2997
2022 Q3	$107K	Sell	2,843 -789	-22%	-$27.3K	﹤0.01%	2508
2022 Q2	$100K	Buy	3,632 +3,255	+863%	+$143K	﹤0.01%	2296
2022 Q1	$21K	Sell	377 -1,300	-78%	-$66.7K	﹤0.01%	3488
2021 Q4	$98K	Buy	1,677 +1,193	+246%	+$59.5K	﹤0.01%	2231
2021 Q3	$19K	Sell	484 -526	-52%	-$18.7K	﹤0.01%	3759
2021 Q2	$43K	Buy	1,010 +448	+80%	+$24.3K	﹤0.01%	3146
2021 Q1	$35K	Buy	562 +370	+193%	+$23.4K	﹤0.01%	3423
2020 Q4	$14K	Sell	192 -6,207	-97%	-$391K	﹤0.01%	4099
2020 Q3	$247K	Buy	6,399 +6,052	+1,744%	+$240K	﹤0.01%	2371
2020 Q2	$13K	Buy	+347	New	+$10.7K	﹤0.01%	3901